Please provide your email address to receive an email when new articles are posted on . The estimated added effect of provocation was not significant for either condition. The findings have ...

The Horizon® 3.0 Inspire has a compact design allowing for easier portability. The Food and Drug Administration (FDA) has cleared Magstim’s Horizon ® 3.0 Inspire for the treatment of major depressive ...

The MarketWatch News Department was not involved in the creation of this content. Phoenix, Arizona--(Newsfile Corp. - March 26, 2026) - Camelback Integrated Health and Wellness, a Phoenix-based ...

BURLINGTON, Mass. and JERUSALEM, Oct. 11, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...

This life-changing Health Canada-approved technology directly targets the brain circuits involved in OCD—without the side effects of medication. Patients tell us they feel like they’re finally getting ...

BURLINGTON, Mass. and JERUSALEM, Nov. 03, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BRSYF) (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...

You’ve heard how Dr. Sonni Elliott of Sunrise Psychiatry treats resistant depression with TMS Therapy. Now Dr. Elliott is offering the treatment for those with obsessive compulsive behaviors. OVERLAND ...

Transcranial magnetic stimulation sounds like — and looks like — something you'd find in a science fiction movie, but it's a real treatment option. This noninvasive therapy uses strong magnets to ...

BUDAPEST — Repetitive transcranial magnetic stimulation (rTMS) can be useful treatment for some people with major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), but its use is only ...

Here in the U.S., some 21 million adults experience at least one major depressive episode each year. About a third of them do not achieve adequate relief from traditional antidepressant medications ...